TY - JOUR
T1 - Evaluation of cholinesterase inhibitory activity of six indonesian cassia species
AU - Suciati, Suciati
AU - Laili, Erlinda Rhohmatul
AU - Poerwantoro, Debora
AU - Hapsari, Anita Probo
AU - Gifanda, Lailatul Zakiyah
AU - Rabgay, Karma
AU - Ekasari, Wiwied
AU - Ingkaninan, Kornkanok
N1 - Publisher Copyright:
© 2020 Marmara University Press.
PY - 2020
Y1 - 2020
N2 - Alzheimer’s disease (AD) is a neurodegenerative disorder, which is the most common cause of dementia. The aging population means that the number of people suffering from AD is expected to increase each year if there is no effective treatment found. One of the strategies for the treatment of AD is the use of cholinesterase inhibitors. Plants have been the source of many bioactive metabolites, including cholinesterase inhibitors. The objective of this study is to investigate the potency of several plant extracts from the genus Cassia as cholinesterase inhibitors. The cholinesterase inhibitory screening was carried out against two enzymes, acetylcholinesterase (AChE) and butyrylcholinesterase (BChE), according to the modified Ellman’s method. The chemistry of the active fractions was studied by LC-MS/MS method. The results suggested that amongst six plant extracts from the genus Cassia investigated, the ethanolic extract of Cassia spectabilis showed the strongest inhibition against both AChE and BChE enzymes, with IC50 values of 39.5 and 36.9 µg/mL, respectively. Investigation on the n-hexane, ethyl acetate, and nbutanol fractions obtained from the C. spectabilis extract showed that the ethyl acetate and the n-butanol fractions gave better inhibitory activity compared to the n-hexane fraction. Based on the LC-MS/MS data, the two active fractions gave similar profile. Both fractions contained alkaloid cassine and spectaline, which may responsible for the cholinesterase inhibitory activity.
AB - Alzheimer’s disease (AD) is a neurodegenerative disorder, which is the most common cause of dementia. The aging population means that the number of people suffering from AD is expected to increase each year if there is no effective treatment found. One of the strategies for the treatment of AD is the use of cholinesterase inhibitors. Plants have been the source of many bioactive metabolites, including cholinesterase inhibitors. The objective of this study is to investigate the potency of several plant extracts from the genus Cassia as cholinesterase inhibitors. The cholinesterase inhibitory screening was carried out against two enzymes, acetylcholinesterase (AChE) and butyrylcholinesterase (BChE), according to the modified Ellman’s method. The chemistry of the active fractions was studied by LC-MS/MS method. The results suggested that amongst six plant extracts from the genus Cassia investigated, the ethanolic extract of Cassia spectabilis showed the strongest inhibition against both AChE and BChE enzymes, with IC50 values of 39.5 and 36.9 µg/mL, respectively. Investigation on the n-hexane, ethyl acetate, and nbutanol fractions obtained from the C. spectabilis extract showed that the ethyl acetate and the n-butanol fractions gave better inhibitory activity compared to the n-hexane fraction. Based on the LC-MS/MS data, the two active fractions gave similar profile. Both fractions contained alkaloid cassine and spectaline, which may responsible for the cholinesterase inhibitory activity.
KW - Alzheimer’s disease
KW - Cassia species
KW - Cassia spectabilis
KW - Cholinesterase inhibitor
UR - http://www.scopus.com/inward/record.url?scp=85089829705&partnerID=8YFLogxK
U2 - 10.35333/jrp.2020.195
DO - 10.35333/jrp.2020.195
M3 - Article
AN - SCOPUS:85089829705
SN - 1309-0801
VL - 24
SP - 472
EP - 478
JO - Journal of Research in Pharmacy
JF - Journal of Research in Pharmacy
IS - 4
ER -